A 55-year-old woman presents with symmetric swelling and morning stiffness of the metacarpophalangeal and proximal interphalangeal joints for 3 months. ESR and CRP are elevated, and rheumatoid factor and anti-CCP antibodies are positive. According to Canadian Rheumatology Association recommendations, what is the most appropriate initial disease-modifying treatment?